Hepion Pharmaceuticals Reports Positive Activity of CRV431 Against Coronavirus SARS-2 in Study Conducted by the National Institute of Allergy and Infectious Diseases
EDISON, NJ / ACCESSWIRE / September 17, 2020 / Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA)(“Hepion”), a biopharmaceutical…
Shook & Stone Opens Up “An Ideal Lawyer’s Portrait: Representation Matters” 2026 Scholarship
Marketing 1on1 Announces the Addition of Local Citations to Its Backlink Service Offerings
Think Business, Think Hong Kong strengthens Italy-Hong Kong ties and opens new path for Asian collaboration
FUTR Announces Q1 2026 Financial Results